← Browse by Condition
Medical Condition
hyperglycemia
Total Trials
9
Recruiting Now
9
Trial Phases
Phase 4, Phase 2
ClinicalMetric tracks all active clinical trials for hyperglycemia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — hyperglycemia Clinical Trials
How many clinical trials are currently recruiting for hyperglycemia?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for hyperglycemia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for hyperglycemia?
hyperglycemia research spans Phase 2 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a hyperglycemia clinical trial?
Eligibility criteria for hyperglycemia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Phase 4 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05702931 Phase 4
Recruiting
Semaglutide Treatment for Hyperglycaemia After Renal Transplantation
Enrollment
104 pts
Location
Denmark
Sponsor
Rigshospitalet, Denmark
NCT06503172 Phase 2
Recruiting
Whole Grain Job's Tear, Muscle Health, Blood Glucose and Lipid Level
Enrollment
80 pts
Location
Taiwan
Sponsor
Taipei Veterans General Hospit...
NCT05447806
Recruiting
Diabetes Clinical Decision Support
Enrollment
15,732 pts
Location
United States
Sponsor
Milton S. Hershey Medical Cent...
NCT06234787
Recruiting
Continuous Subcutaneous Glucose Monitoring in Critical Patients
Enrollment
245 pts
Location
Spain
Sponsor
Universidad Europea de Madrid
NCT06116149
Recruiting
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
Enrollment
722 pts
Location
United States
Sponsor
Tulane University
NCT06852950
Recruiting
Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
Enrollment
60 pts
Location
United States
Sponsor
Vanderbilt University Medical ...
NCT07218133
Recruiting
Trans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery
Enrollment
50 pts
Location
United States
Sponsor
Alexander T. Yahanda
NCT05132244
Recruiting
Monitoring and Managing Glucose Levels in People With Pancreatic Cancer
Enrollment
50 pts
Location
Canada
Sponsor
British Columbia Cancer Agency
NCT06893341
Recruiting
Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events
Enrollment
30 pts
Location
United States
Sponsor
Indiana University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology